High expression of PENK is associated with improved outcomes in GIST patients and is postulated to act as a tumor suppressor [42], inhibit breast tumor growth [41], and is required, in part, for induction of apoptosis through the NF-κB/p53 pathway [59]. This evidence concerns the gene NFKB1 and neoplasm.